| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/08/2023 | F-star Therapeutics, Inc. | SBPH | Disposition | Stock Option (right to buy) | 20k | $6.88 | $137.6k | | 03/08/2023 |
| 03/08/2023 | F-star Therapeutics, Inc. | SBPH | Disposition | Stock Option (right to buy) | 34.1k | $16.62 | $566.9k | | 03/08/2023 |
| 03/08/2023 | F-star Therapeutics, Inc. | SBPH | Disposition | Common Stock | 6.3k | $7.12 | $45.1k | | 03/08/2023 |
| 03/08/2023 | F-star Therapeutics, Inc. | SBPH | Other | Common Stock | 97.5k | $7.12 | $694.5k | | 03/08/2023 |
| 03/08/2023 | F-star Therapeutics, Inc. | SBPH | Disposition | Stock Option (right to buy) | 20k | $3.41 | $68.2k | | 03/08/2023 |
| 06/17/2022 | F-star Therapeutics, Inc. | SBPH | Grant | Stock Option | 20k | $3.41 | $68.2k | | 06/17/2022 |
| 06/04/2021 | F-star Therapeutics, Inc. | SBPH | Grant | Stock Option | 20k | $6.88 | $137.6k | | 06/04/2021 |
| 02/01/2021 | F-star Therapeutics, Inc. | SBPH | Grant | Common Stock | 87k | $0.00 | $0 | | 02/01/2021 |
| 11/20/2020 | F-star Therapeutics, Inc. | SBPH | Grant | Stock Option (right to buy) | 34.1k | $16.62 | $566.9k | | 11/20/2020 |
| 11/20/2020 | F-star Therapeutics, Inc. | SBPH | Grant | Restricted Stock Units | 16.9k | $0.00 | $0 | | 11/20/2020 |
| 11/20/2020 | F-star Therapeutics, Inc. | SBPH | Grant | | 16.9k | $0.00 | $0 | | 11/20/2020 |
| 12/12/2017 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 292.5k | $18.30 | $5.4M | | 12/12/2017 |
| 12/08/2017 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 94.1k | $20.82 | $2M | | 12/06/2017 |
| 12/07/2017 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 27.6k | $21.46 | $591.5k | | 12/06/2017 |
| 12/07/2017 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 103.6k | $21.05 | $2.2M | | 12/06/2017 |
| 12/06/2017 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 12.5k | $20.84 | $259.8k | | 12/06/2017 |
| 12/06/2017 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 99k | $20.28 | $2M | | 12/06/2017 |
| 06/01/2017 | Intellia Therapeutics, Inc. | NTLA | Grant | Common Stock | 8.4k | $11.95 | $100.4k | | 06/01/2017 |